Iradimed Corp (IRMD) was Downgraded by ROTH Capital to ” Neutral”. Earlier the firm had a rating of “Buy ” on the company shares. ROTH Capital advised their investors in a research report released on Oct 5, 2016.
On the company’s financial health, Iradimed Corp reported $0.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 29, 2016. Analyst had a consensus of $0.21. The company had revenue of $9.90 million for the quarter, compared to analysts expectations of $9.61 million. The company’s revenue was up 30.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.16 EPS.
Iradimed Corp closed down -6.24 points or -36.68% at $10.77 with 8,95,641 shares getting traded on Tuesday. Post opening the session at $12.24, the shares hit an intraday low of $9.7575 and an intraday high of $12.54 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
In a different news, on Sep 2, 2016, Louis S. Waldman (Controller) sold 23,162 shares at $19.00 per share price. According to the SEC, on Aug 16, 2016, Steven M. Nardi (VP of Manufacturing) sold 2,096 shares at $17.17 per share price. On Jun 14, 2016, Monty K Allen (director) sold 2,275 shares at $20.00 per share price, according to the Form-4 filing with the securities and exchange commission.
IRADIMED CORPORATION (IRADIMED) develops manufactures markets and distributes Magnetic Resonance Imaging (MRI) compatible products and provides non-magnetic intravenous (IV) infusion pump systems. The Company’s electromechanical medical devices and pumps contain magnetic and electronic parts which generate radio frequency (RF) noise create interference and are dangerous to operate in the presence of the magnet which drives an MRI. The Company’s MRidium 3860+ MRI compatible IV infusion pump system consists of non-ferrous parts ceramic ultrasonic motors non-magnetic mobile stands and other special features to deliver anesthesia and other IV fluids during various MRI procedures. As of December 31 2014 the Company had approximately 2300 MRI compatible IV infusion pump systems installed globally. Each system consists of an MRidium MRI compatible IV infusion pump mobile stand and disposable IV tubing sets.